ACMA Instructor Dr.


Other Online Trainings Provided:
  1. Overview of Medical Information
  2. Diversity in Clinical Trials
  3. Clinical Trial Designs
  4. Abstract & Medical Writing
  5. Grant & Investigator Initiated Study Funding and Process
  6. Clinical Trial Designs
  7. Abstract & Medical Writing
  8. Basic Principles in Pharmacology
  9. Prevention of Prescription Drug Fraud and Abuse
  10. High Value Selling
  11. Analyzing Peer-Reviewed Literature on Pharmacological Treatments
  12. Phase IV/Post-Marketing Studies
  13. Publication Practices
  14. Publication Practices
  15. Health Economics Outcomes Research
  16. Drug Development Process
  17. Overview of Medical Information
  18. Medication Safety & Pharmacovigilance
  19. Medication Safety & Pharmacovigilance
  20. The Pharmaceutical Industry Overview
  21. Regulatory Affairs in Brazil
  22. Overview of Medical Information
  23. Regulatory Affairs in India
  24. The Pharmaceutical Industry Overview
  25. Regulatory Affairs in Asia: Focus on China, Japan, Singa-pore, Hong Kong
  26. Regulatory Affairs Overview in Europe
  27. Anatomical & Physiological Effects of Drugs
  28. Clinical Development Expert Program
  29. The Pharmaceutical Industry Overview
  30. Rules Governing Interactions with Healthcare Professionals
  31. Regulatory Affairs
  32. Medical Terminology & Abbreviations
  33. FDA Laws and Regulations Related to Pharmaceutical Industry Marketing
  34. Principles of Pharmacoeconomics
  35. Introduction to Opioid Use for Pharmaceutical Industry Professionals
  36. Comparison of Therapeutic Drug Classes
  37. Coverage Determination Types in Medication Prior Authorizations
  38. Insurance Policies
  39. Rules Governing Interactions with Healthcare Professionals
  40. The Pharmaceutical Industry Overview
  41. Properly Using Guidelines from Insurance Plan
  42. Service Line, Medication Initiation & Submission of a Prior Authorization
  43. The Authorization Process
  44. Fundamentals of Clinical Development
  45. Out of Network Waivers
  46. Understanding Medical Evidence
  47. Regulatory & Compliance Rules Influencing the Pharmaceutical Industry
  48. The Medical Devices Industry & Overview
  49. Understanding Medical Terminology
  50. Drug Development & the Pharmaceutical Industry
  51. Drug Development & the Pharmaceutical Industry
  52. Drug Research Post Commercialization
  53. Drug Research Post Commercialization
  54. Pharmacological Fundamentals
  55. Pharmacological Fundamentals
  56. Risk Evaluation and Mitigation Strategies (REMS)
  57. Compliant Interactions with Health Care Providers
  58. Authorization Denials and Appeals
  59. The Prior Authorization Process
  60. The Future of Prior Authorizations and Job Opportunities
  61. Medical Records and The Prescription
  62. Rules Governing Interactions with Healthcare Professionals
  63. Health Economics Outcomes Research
  64. Health Economics Outcomes Research
  65. Clinical Trial Designs
  66. Drug Development Process
  67. Evidence Based Medicine
  68. Overview of Medical Information
  69. Medical Science Liaisons & Field Based Medical Teams
  70. Grant & Investigator Initiated Study Funding and Process
  71. Advisory Boards
  72. Presentation & Communication Skills
  73. Phase IV/Post-Marketing Studies
  74. Risk Evaluation and Mitigation Strategies (REMS)
  75. The Pharmaceutical Industry Overview
  76. Medical Device Industry
  77. Compliance
  78. Diagnostics Industry
  79. Rules Governing Interactions with Healthcare Professionals
  80. Evidence Based Medicine
  81. Medication Safety & Pharmacovigilance
  82. Communication Methods of the Prior Authorization
  83. Health Economics Outcomes Research
  84. Drug Development Process
  85. Evidence Based Medicine
  86. Drug Development Process
  87. Overview of Medical Information
  88. Medical Science Liaisons & Field Based Medical Teams
  89. Medical Science Liaisons & Field Based Medical Teams
  90. Grant & Investigator Initiated Study Funding and Process
  91. Advisory Boards
  92. Medication Safety & Pharmacovigilance
  93. Advisory Boards
  94. Fundamental Information Before the Authorization Process
  95. Phase IV/Post-Marketing Studies
  96. Health Economics Outcomes Research
  97. Presentation & Communication Skills
  98. Regulatory Affairs
  99. Risk Evaluation and Mitigation Strategies (REMS)
  100. Rules Governing Interactions with Healthcare Professionals
  101. Compliance
  102. Post-Approval Studies
  103. Risk Evaluation and Mitigation Strategies (REMS)
  104. Overview of Medical Information - Content Only
  105. Medical Science Liaisons & Field Based Medical Teams - Content Only
  106. Phase IV/Post-Marketing Studies - Content Only
  107. Medical Device Industry - Content Only
  108. Diagnostics Industry - Content Only
  109. Health Economics Outcomes Research - Content Only
  110. Grant & Investigator Initiated Study Funding and Process - Content Only
  111. Advisory Boards - Content Only
  112. Healthcare Compliance Attestation
  113. Medical Device Industry
  114. Regulatory Affairs
  115. Overview of Medical Information
  116. Advisory Boards
  117. Compliance
  118. Regulatory Affairs in China
  119. Drug Development Process
  120. Compliance
  121. Abstract & Medical Writing
  122. Publication Practices
  123. Medical Science Liaisons & Field Based Medical Teams
  124. The Pharmaceutical Industry Overview
  125. The Pharmaceutical Industry Overview
  126. Diagnostics Industry
  127. Rules Governing Interactions with Healthcare Professionals
  128. Clinical Trial Designs
  129. Presentation & Communication Skills
  130. Regulatory Affairs
  131. Compliance
  132. Abstract & Medical Writing
  133. Publication Practices
  134. Phase IV/Post-Marketing Studies
  135. PhRMA Code Attestation
  136. Medical Device Industry
  137. Publication Practices
  138. Future of Pharma Industry Careers
  139. Regulatory Affairs
  140. Publication Practices
  141. Risk Evaluation and Mitigation Strategies (REMS)
  142. Diagnostics Industry
  143. Diagnostics Industry
  144. Compliance HIPAA, Security, Fraud and Abuse
  145. The Role of Drugs on Human Physiology
  146. Regulatory Affairs
  147. Grant & Investigator Initiated Study Funding and Process
  148. Risk Evaluation and Mitigation Strategies (REMS)
  149. Medical Device Industry
  150. Rules Governing Interactions with Healthcare Professionals
  151. Health Economics Outcomes Research
  152. Evidence Based Medicine
  153. Clinical Trial Designs
  154. Presentation & Communication Skills
  155. Grant & Investigator Initiated Study Funding and Process
  156. Phase IV/Post-Marketing Studies
  157. Risk Evaluation and Mitigation Strategies (REMS)
  158. Medication Safety & Pharmacovigilance
  159. Diagnostics Industry
  160. Regulatory & Compliance Rules Influencing the Pharmaceutical Industry
  161. Compliance
  162. Principles of Pharmacoeconomics
  163. The Medical Devices Industry & Overview
  164. Medical Device Industry
  165. Medication Safety & Pharmacovigilance
  166. Understanding Medical Terminology
  167. Rules Governing Interactions with Healthcare Professionals
  168. Health Economics Outcomes Research
  169. Evidence Based Medicine
  170. Presentation & Communication Skills
  171. Medical Science Liaisons & Field Based Medical Teams
  172. Grant & Investigator Initiated Study Funding and Process
  173. Medical Device Industry
  174. Understanding Types of Clinical Trials
  175. Diagnostics Industry
  176. Fraud & Abuse in the Pharmaceutical Industry
  177. Medical Device Industry
  178. Health Economics Outcomes Research
  179. Clinical Trial Designs
  180. Compliance
  181. Medical Science Liaisons & Field Based Medical Teams
  182. Grant & Investigator Initiated Study Funding and Process
  183. The Pharmaceutical Industry Overview - Content Only
  184. Rules Governing Interactions with Healthcare Professionals - Content Only
  185. Regulatory Affairs - Content Only
  186. Compliance - Content Only
  187. Abstract & Medical Writing - Content Only
  188. Publication Practices - Content Only
  189. Drug Development Process - Content Only
  190. Clinical Trial Designs
  191. Presentation & Communication Skills
  192. Abstract & Medical Writing
  193. Drug Development Process
  194. Diagnostics Industry
  195. Medical Science Liaisons & Field Based Medical Teams
  196. Risk Evaluation and Mitigation Strategies (REMS)
  197. Compliant Interactions with Health Care Providers
  198. Clinical Trial Designs - Content Only
  199. Presentation & Communication Skills - Content Only
  200. Risk Evaluation and Mitigation Strategies (REMS) - Content Only
  201. Special Considerations for Service Orders
  202. Diagnostics Industry
  203. Evidence Based Medicine
  204. Advisory Boards
  205. The Pharmaceutical Industry Overview
  206. The Pharmaceutical Industry Overview
  207. Diagnostics Industry
  208. Advisory Boards
  209. Presentation & Communication Skills
  210. Medication Safety & Pharmacovigilance - Content Only
  211. Risk Evaluation and Mitigation Strategies (REMS)
  212. Interpreting Clinical Papers
  213. Regulatory Affairs
  214. Regulatory Affairs
  215. Compliance
  216. Evidence Based Medicine
  217. Abstract & Medical Writing
  218. Publication Practices
  219. Abstract & Medical Writing
  220. Publication Practices
  221. Drug Development Process
  222. Overview of Medical Information
  223. Advisory Boards
  224. Phase IV/Post-Marketing Studies
  225. Medication Safety & Pharmacovigilance
  226. Medical Science Liaisons & Field Based Medical Teams

Our Authors

 ACMA Instructor